Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,441
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for
Non Small Cell Lung Cancer, Esophageal Cancer,
Location: Seattle WA, Beverly Hills CA, Duarte CA,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT05983432
Phase1, Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
for
Neuroendocrine Tumors Unresectable,
Location: Seattle WA, Omaha NE, Rochester MN, Iowa City IA,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05636618
Phase1, Phase2, Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer
Location: Seattle WA, San Francisco CA, Murray UT, Duarte CA,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT04221542
Phase1, Recruiting
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Seattle WA, Sacramento CA, Billings MT,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase1, Phase2, Recruiting
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Seattle WA, Phoenix AZ, Rochester MN, Chicago IL,
Sponsor: Chordia Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05732103
Phase1, Phase2, Recruiting
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Seattle WA, St Louis MO, Chapel Hill NC
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06179303
Phase2, Recruiting
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
for
Castration Resistant Metastatic Prostate Cancer
Location: Seattle WA, San Diego CA, Omaha NE, Minneapolis MN,
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: Male
Age: 18 - 70+
Code: NCT04363164
Phase2, Recruiting
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Seattle WA, Salt Lake City UT, Colorado Springs CO,
Sponsor: ORIC Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05413421
Phase1, Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Seattle WA, Las Vegas NV, Duarte CA, Orange CA,
Sponsor: J-Pharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT07265674
Phase3, Recruiting
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
for
Myelodysplastic/Myeloproliferative Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT07228624
Phase2, Recruiting
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 3+
Code: NCT05866302
Recruiting
Sustained Oral Fiber Supplementation for Patients Undergoing Treatment for Hematological Malignancies
for
Hematopoietic and Lymphatic System Neoplasm
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT04829136
Recruiting
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease